ReviveMed uses AI to gather large-scale data on metabolites — molecules like lipids, cholesterol, and sugar — to match patients with therapeutics.
Researchers at The Wistar Institute’s HIV Cure and Viral Diseases Center have successfully identified a new approach using natural killer (NK) cells to target and kill the HIV-positive cells that allow the virus to persist. Wistar scientists have labeled this new approach “NuKES”: Natural Killer Enhancement Strategy.
Gene editing techniques may eventually allow trisomy to be treated at the cellular level, according to an in vitro proof-of-concept study.
Researchers have developed comfortable, washable “smart pajamas” that can monitor sleep disorders such as sleep apnea at home, without the need for sticky patches, cumbersome equipment or a visit to a specialist sleep clinic.
Scientists have developed a breakthrough method to track diet using stool metagenomic data.
A sponge-like implant in mice has helped guide a treatment that slowed or stopped a degenerative condition similar to multiple sclerosis in humans. It has also given University of Michigan researchers a first look at how primary progressive multiple sclerosis, the fastest-progressing version of the disease, attacks the central nervous system early on.
SAN FRANCISCO, Feb. 18, 2025 /PRNewswire/ — Wrong-site surgery (WSS), a critical “Never Event,” represents a failure that should never occur in healthcare. Yet, due to underreporting, the true prevalence of these incidents remains obscured, jeopardizing patient safety and healthcare management. AESOP Technology, a medical AI startup, has developed an innovative solution: the Association Outlier Pattern (AOP) machine learning model. This model offers real-time decision support and retrospective analysis, aimed at enhancing surgical safety and care quality.
BETHLEHEM, Pa., Feb. 18, 2025 /PRNewswire/ — B. Braun Medical Inc. (B. Braun), the U.S. market leader in regional anesthesia (RA), announced today the launch of the Emergency Department Single-Shot Nerve Block Tray to the U.S. market.1 The tray is specifically designed for emergency departments and supports clinicians in providing safe, effective pain management while reducing opioid use and its complications in acute care settings.2 Featuring advanced echogenic technology for improved ultrasound visibility, it is the first ever peripheral nerve block (PNB) tray to include our Ultraplex® 360 Needle, which is preferred by 91% of clinicians over competing options.3
Pancreatic cancer (PC) is the worst prognosis cancer globally, with just 13% of patients who are diagnosed with PC surviving for 5 years or more after initial diagnosis. In Ireland, there are approximately 900 cases of PC per year, and 820 PC-related deaths. Early detection of PC is the primary concern of most PC research, as it has the potential to make a substantial difference to the treatment and survival of patients.
Pancreatic cancer is fueled by connections to the nervous system. This is reported by scientists from the German Cancer Research Center (DKFZ) and the Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM) in Nature.